Table 1.

Cell doubling times in days of BT474, T-47D, and HCC1806 BC target cells grown as ML as a function of AEB071 treatment. In addition, % changes compared to untreated cells are given

Cell line	No treatment (ctrl)	AEB071 (5 µM)		AEB071 (20 µM)
	Days	Days	Change	Days	Change
BT474	3.93	4.27	+ 8.7%	5.72	+ 45.5%
T-47D	2.35	2.5	+ 6.4%	4.27	+ 81.7%
HCC1806	1.41	1.46	+ 3.55%	1.75	+ 24.1%